Primary pancreatic Burkitt's lymphoma mimicking carcinoma with obstructive jaundice and very high CA19-9

European Journal of Gastroenterology and Hepatology

Volumn 18, Issue 5, 2006, Pages 537-540

  Wang, Yu Jen ^a,b   Jeng, Chin Ming ^a   Wang, Young Chen ^a   Chang, Pi Peng ^a   Wang, Tsung His ^a  

^a CATHAY GENERAL HOSPITAL   (Taiwan)

^b NONE   (Taiwan)

Author keywords

Carbohydrate antigen 19 9 (CA19 9); Computed tomography (CT); Lymphoma; Magnetic resonance imaging (MRI); Pancreas

Indexed keywords

CA 19-9 ANTIGEN; TUMOR MARKER;

ADULT; ANAMNESIS; ARTICLE; BURKITT LYMPHOMA; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; ENDOSCOPIC BIOPSY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HISTOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; LAPAROTOMY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSTRUCTIVE JAUNDICE; PANCREAS CARCINOMA; PANCREAS TUMOR; PANCREATICODUODENECTOMY; PRIORITY JOURNAL;

BURKITT LYMPHOMA; CA-19-9 ANTIGEN; DIAGNOSIS, DIFFERENTIAL; FATAL OUTCOME; HUMANS; JAUNDICE, OBSTRUCTIVE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33744798763     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200605000-00014     Document Type: Article

References (19)

1. Boni L, Benevento A, Dionigi G, Cabrini L, Dionigi R. Primary pancreatic lymphoma. Surg Endosc 2002; 16:1107-1108.
2. Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer 1972; 29:252-260.
3. Steinberg W. The clinical utility of CA19-9 tumor associated antigen. Am J Gastroenterol 1990; 85:350-355.
4. Anwar N, Kingma DW, Bloch AR, Mourad M, Raffeld M, Franklin J, et al. The investigation of Epstein-Barr viral sequences in 41 cases of Burkitt's lymphoma from Egypt. Cancer 1995; 76:1245-1252.
5. Chao TY, Wang TY, Lee WH. Association between Epstein-Barr virus and Burkitt's lymphoma in Taiwan. Cancer 1997; 80:121-128.
6. Hamilton-Dutoit SJ, Pallesen G. Detection of Epstein-Barr virus small RNAs in routine paraffin sections using non-isotopic RNA/RNA in situ hybridization. Histopathology 1994; 25:101-111.
7. Levine PH, Connelly RR, Berard CW, O' Connor GT, Dorfman RF, Easton JM, et al. The American Burkitt's lymphoma registry: a progress report. Ann Intern Med 1975; 83:31-36.
8. Jones WF, Sheikh MY, McClave SA. AIDS-related non-Hodgkin's lymphoma of the pancreas. Am J Gastroenterol 1997; 92:335-358.
9. Islam S, Callery MP. Primary pancreatic lymphoma - a diagnosis to remember. Surgery 2001; 129:380-383.
10. Bouvet M, Staerkel GA, Spitz FR, Curley SA, Charnsangavej C, Hagemeister FB, et al. Primary pancreatic lymphoma. Surgery 1998; 123:382-390.
11. Nayer H, Weir EG, Sheth S, Ali SZ. Primary pancreatic lymphoma. Cancer Cytopathology 2004; 102:315-321.
12. Forsmark CE, Lambiase L, Vogel SB. Diagnosis of pancreatic cancer and prediction of unresectability using the tumor-associated antigen CA19-9. Pancreas 1994; 9:731-734.
13. Minghini A, Weireter LJ, Perry Roger R. Specificity of elevated CA 19-9 in chronic pancreatitis. Surgery 1998; 124:103-105.
14. Behrns KE, Sarr MG, Strickler JG. Pancreatic lymphoma: is it a surgical disease? Pancreas 1994; 9:662-667.
15. Brown PC, Hart MJ, White TT. Pancreatic lymphoma, diagnosis and management. Int J Pancreatol 1987; 2:93-100.
16. James JA, Milligan DW, Morgan GJ, Crocker J. Familial pancreatic lymphoma. J Clin Pathol 1998; 51:80-82.
17. Webb TH, Lillemoe KD, Pitt HA, Jones RJ, Cameron JL. Pancreatic lymphoma: is surgery mandatory for diagnosis or treatment? Ann Surg 1989; 209:25-30.
18. Hamm M, Rottger P, Fiedler C. Primary non-Hodgkin lymphoma of pancreas. Chirurg 1998; 69:301-305.
19. Kawakami K, Nomura H, Watanabe Y, Momma F. Primary pancreatic lymphoma with elevated serum CA 19-9 level. Rinsho Ketsueki 2002; 43:292-297.